Adela Announces Clinical Validation Results for Head & Neck Cancer MRD Test Simultaneously Published in Annals of Oncology and Presented at ESMO 2024
Adela’s tissue-agnostic MRD test has been clinically validated to predict and surveil for recurrence in patients with head & neck cancer, regardless of HPV status The test identified recurrences in head & neck cancer up to 14.9 months before standard of care clinical exam and imaging F
SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024
Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most benefit from combination immunotherapy BOSTON and ROLLE, Switzerland, Sept. 14, 2024 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare
DIRECTV AND THE WALT DISNEY COMPANY REACH AGREEMENT IN PRINCIPLE FOR DISTRIBUTION OF DISNEY’S LINEAR NETWORKS AND DIRECT-TO-CONSUMER SERVICES
All Channels Immediately Restored to DIRECTV Satellite, Streaming, and U-verse Customers New, Robust Agreement Includes Disney’s Full Portfolio of Networks and Direct-to-Consumer Services, Genre-Specific Options, and ESPN’s Flagship Direct-to-Consumer Offering When It Launches in 2025 BU
KuCoin Cares Extends up to 10,000 KCS Humanitarian Aid to Typhoon Yagi Victims in Vietnam
VICTORIA, Seychelles, Sept. 14, 2024 /PRNewswire/ — In a prompt response to the devastating impact of Typhoon Yagi in Northern Vietnam, KuCoin is committed to airdropping up to 10,000 KCS to support the communities affected by the disaster. This donation is designed to provide immediate aid an
SmallRig Unveils Three Innovative Products at the IBC Show 2024 in the Netherlands
AMSTERDAM, Sept. 14, 2024 /PRNewswire/ — SmallRig recently showcased three innovative products at the IBC Show 2024 in the Netherlands. These cutting-edge releases are designed to revolutionize the way creators approach lighting and equipment management. SmallRig x FILM RIOT 7 & 10-in-1 F
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
NANJING, China, Sept. 14, 2024 /PRNewswire/ — On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough Therapy designation by th
Xinhua Silk Road: Jiangcun Academy, a new highland for rural revitalization and social science research under construction in E. China’s Suzhou
BEIJING, Sept. 14, 2024 /PRNewswire/ — The educational project Jiangcun Academy aimed at inheriting and promoting the scholarly spirit of Chinese renowned sociologist Fei Xiaotong is under construction in Kaixiangong Village, Wujiang District in Suzhou City of east China’s Jiangsu Provi
Iconic Supermodels Helena Christensen and Sean O’Pry Lead the NYFW Debut of E-commerce Powerhouses Ekouaer and Coofandy
NEW YORK, Sept. 14, 2024 /PRNewswire/ — International menswear brand Coofandy and women’s sleepwear label Ekouaer made a bold entrance at New York Fashion Week with their much-anticipated runway debut at the landmark Cipriani building, 25 Broadway. As e-commerce leaders in their respecti
Chengdu booming as global e-commerce hub
CHENGDU, China, Sept. 14, 2024 /PRNewswire/ — With cross-border trade representing a new direction for e-commerce in recent years, cross-border e-commerce in Chengdu has experienced explosive growth. Its public service platforms completed more than 61 million import and export declarations in
Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)
In Phase Ia clinical study, GZR4 demonstrated favorable safety and tolerability profiles in healthy subjects, maintaining a stable glucose-lowering effect for up to one week with a single administration.In Phase Ib clinical study, patients with Type 2 diabetes mellitus (T2DM) receiving six weeks of
